Xiamen Amoytop Biotech Co., Ltd. (688278.SS)
CNY 71.53
(1.26%)
CNY 71.53
(1.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 512.1 Million | 363.16 Million | 234.78 Million | 92.6 Million | 123.3 Million | 89.14 Million |
| Net Income | 555.44 Million | 287.01 Million | 181.2 Million | 116.56 Million | 64.29 Million | 16 Million |
| Depreciation & Amortization | 58.69 Million | 48.07 Million | 43.15 Million | 38.16 Million | 37.77 Million | 37.54 Million |
| Deferred income taxes | -11.22 Million | -2.6 Million | -7.52 Million | 87.15 Thousand | 2.25 Million | -16.3 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -121.07 Million | 30.52 Million | 14.98 Million | -61.66 Million | 15.24 Million | 33.3 Million |
| Other non-cash items | 19.03 Million | -2.46 Million | -4.56 Million | -461.91 Thousand | 5.98 Million | 2.29 Million |
| Investing Cash Flow | -305.76 Million | -289.39 Million | -111.84 Million | -381.99 Million | -44.73 Million | -14.54 Million |
| Investments in PPE | -288.46 Million | -219.16 Million | -190.92 Million | -118.81 Million | -44.82 Million | -14.6 Million |
| Acquisitions | 0.61 | 107.2 Thousand | 339.77 Thousand | 118.86 Million | 95 Thousand | 55 Thousand |
| Investment purchases | -616 Million | -700 Million | -754.57 Million | -1.14 Billion | - | - |
| Sales/Maturities of investments | 598.65 Million | 629.66 Million | 833.31 Million | 884.85 Million | - | - |
| Other Investing Activities | 44.1 Thousand | 0.98 | 1.50 | -118.81 Million | -44.82 Million | 55 Thousand |
| Financing Cash Flow | -92.9 Million | -58.36 Million | -34.2 Million | 281.11 Million | -17.86 Million | -13.75 Million |
| Debt repayment | -6.26 Million | -10 Million | -18.91 Million | -41.08 Million | -70 Million | -120 Million |
| Dividends payments | -86.64 Million | -40.68 Million | -20.34 Million | -10.17 Million | -3.39 Million | -3.75 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | -13.24 Million | - | - |
| Other Financing Activities | -6.26 Million | -7.68 Million | 5.39 Million | 293.83 Million | 55.52 Million | 110 Million |
| Accounts receivables | -205.75 Million | -15.51 Million | -24.53 Million | -42.41 Million | 9.06 Million | -1.13 Million |
| Accounts payables | 153.19 Million | 61.88 Million | 63.91 Million | 9.68 Million | 19.25 Million | 64.61 Million |
| Inventory | -57.28 Million | -13.23 Million | -16.87 Million | -29.02 Million | -15.31 Million | -13.86 Million |
| Other working capital | -11.22 Million | -2.6 Million | -7.52 Million | 87.15 Thousand | 2.25 Million | 47.16 Million |
| Cash at beginning of period | 300.33 Million | 284.9 Million | 196.65 Million | 205.88 Million | 145.06 Million | 83.82 Million |
| Cash at end of period | 412.65 Million | 300.33 Million | 284.9 Million | 196.65 Million | 205.88 Million | 145.06 Million |
| Capital Expenditure | -288.46 Million | -219.16 Million | -190.92 Million | -118.81 Million | -44.82 Million | -14.6 Million |
| Effect of forex changes on cash | -1.1 Million | 27.59 Thousand | -485.69 Thousand | -956.28 Thousand | 116.67 Thousand | 397.98 Thousand |
| Net cash flow / Change in cash | 112.31 Million | 15.42 Million | 88.25 Million | -9.22 Million | 60.82 Million | 61.24 Million |
| Free Cash Flow | 223.63 Million | 143.99 Million | 43.85 Million | -26.2 Million | 78.47 Million | 74.54 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 249.8 Million | 175.53 Million | 128.8 Million | 186.54 Million | 555.44 Million | 166.72 Million |
| Depreciation & Amortization | - | 21.96 Million | 21.96 Million | 19.47 Million | 58.69 Million | -26.29 Million |
| Deferred income taxes | - | - | - | - | -11.22 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -188.84 Million | - | -263.04 Million | -121.07 Million | 170.17 Million |
| Other non-cash items | -30.19 Million | -159.83 Million | -50.14 Million | 186.17 Million | 19.03 Million | 21.68 Million |
| Investing Cash Flow | -170.12 Million | -195.94 Million | 165.73 Million | -238.61 Million | -305.76 Million | -122.6 Million |
| Investments in PPE | -59.76 Million | -52.21 Million | -78.42 Million | -93.13 Million | -288.46 Million | -43 Million |
| Acquisitions | 930.00 | 60.00 | -244.1 Million | 1550.00 | 0.61 | 41.95 Thousand |
| Investment purchases | -220 Million | -239 Million | -99.41 Million | -311 Million | -616 Million | -160 Million |
| Sales/Maturities of investments | 109.63 Million | 95.27 Million | 343.51 Million | 165.52 Million | 598.65 Million | 80.36 Million |
| Other Investing Activities | 930.00 | -143.72 Million | 53.09 Thousand | 0.52 | 44.1 Thousand | 0.97 |
| Financing Cash Flow | -1.18 Million | -168.27 Million | -1.91 Million | -2.76 Million | -92.9 Million | -1.21 Million |
| Debt repayment | - | - | - | - | -6.26 Million | - |
| Dividends payments | - | -166.78 Million | - | - | -86.64 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.18 Million | 1.91 Million | -1.91 Million | -2.76 Million | -6.26 Million | -1.21 Million |
| Accounts receivables | - | -145.75 Million | - | -205.75 Million | -205.75 Million | 146.67 Million |
| Accounts payables | - | - | - | - | 153.19 Million | - |
| Inventory | - | -43.09 Million | - | -57.28 Million | -57.28 Million | 23.49 Million |
| Other working capital | - | - | - | - | -11.22 Million | - |
| Cash at beginning of period | 284.59 Million | 655.37 Million | 412.65 Million | 524.88 Million | 300.33 Million | 316.51 Million |
| Cash at end of period | 332.95 Million | 284.9 Million | 655.07 Million | 412.65 Million | 412.65 Million | 524.88 Million |
| Capital Expenditure | -59.76 Million | -52.21 Million | -78.42 Million | -93.13 Million | -288.46 Million | -43 Million |
| Effect of forex changes on cash | 52.49 Thousand | -2474.42 | -61.38 Thousand | -11.78 Thousand | -1.1 Million | -99.36 Thousand |
| Net cash flow / Change in cash | 48.35 Million | -370.47 Million | 242.42 Million | -112.23 Million | 112.31 Million | 208.37 Million |
| Free Cash Flow | 159.84 Million | -58.47 Million | 239.02 Thousand | 36.01 Million | 223.63 Million | 289.28 Million |
002240
8613
MANTA
PFIE
CBGH
002678